{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T05:09:28Z","timestamp":1790226568042,"version":"4.1.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer\/Radioth\u00e9rapie"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.canrad.2023.06.012","type":"journal-article","created":{"date-parts":[[2023,7,26]],"date-time":"2023-07-26T10:00:54Z","timestamp":1690365654000},"page":"15-21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Place of radiotherapy for treatment of metastatic cervical, vaginal and endometrial uterine cancer"],"prefix":"10.1016","volume":"28","author":[{"given":"A.","family":"Escande","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Leblanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.-M.","family":"Hannoun-Levi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Renard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Ducassou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Hennequin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Chargari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canrad.2023.06.012_bib0325","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.radonc.2018.03.003","article-title":"The European Society of Gynaecological Oncology\/European Society for Radiotherapy and Oncology\/European Society of Pathology guidelines for the management of patients with cervical cancer","volume":"127","author":"Cibula","year":"2018","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2023.06.012_bib0330","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1056\/NEJMoa2112435","article-title":"Pembrolizumab for persistent, recurrent, or metastatic cervical cancer","volume":"385","author":"Colombo","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2023.06.012_bib0335","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1016\/j.radonc.2020.10.037","article-title":"Management of oligo-metastatic and oligo-recurrent cervical cancer: A pattern of care survey within the EMBRACE research network","volume":"155","author":"Chopra","year":"2021","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2023.06.012_bib0340","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.ygyno.2020.03.006","article-title":"Comprehensive analysis of patient outcome after local recurrence of locally advanced cervical cancer treated with concomitant chemoradiation and image-guided adaptive brachytherapy","volume":"157","author":"Mignot","year":"2020","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.canrad.2023.06.012_bib0345","doi-asserted-by":"crossref","first-page":"e157","DOI":"10.1016\/S1470-2045(19)30855-1","article-title":"Definitive radiotherapy with image-guided adaptive brachytherapy for primary vaginal cancer","volume":"21","author":"Westerveld","year":"2020","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2023.06.012_bib0350","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.canrad.2021.11.014","article-title":"Role of radiotherapy in the treatment of primary vaginal cancer: Recommendations of the French society for radiation oncology","volume":"26","author":"Chargari","year":"2022","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2023.06.012_bib0355","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1001\/jamaoncol.2018.2677","article-title":"Association of definitive pelvic radiation therapy with survival among patients with newly diagnosed metastatic cervical cancer","volume":"4","author":"Wang","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.canrad.2023.06.012_bib0360","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1001\/jamaoncol.2018.5096","article-title":"Level of evidence and ethical considerations for locoregional treatments in metastatic cervical cancer","volume":"5","author":"Schernberg","year":"2019","journal-title":"JAMA Oncol"},{"issue":"6","key":"10.1016\/j.canrad.2023.06.012_bib0365","doi-asserted-by":"crossref","first-page":"e377","DOI":"10.1016\/j.prro.2018.05.010","article-title":"Definitive local therapy is associated with improved overall survival in metastatic cervical cancer","volume":"8","author":"Venigalla","year":"2018","journal-title":"Pract Radiat Oncol"},{"key":"10.1016\/j.canrad.2023.06.012_bib0370","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1136\/ijgc-2020-002031","article-title":"Use of bevacizumab before or after radiotherapy increases the risk of fistula formation in patients with cervical cancer","volume":"31","author":"Kim","year":"2021","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.canrad.2023.06.012_bib0375","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.radonc.2016.03.011","article-title":"Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study","volume":"120","author":"Sturdza","year":"2016","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2023.06.012_bib0380","first-page":"5103","article-title":"Stereotactic body radiotherapy for recurrent or oligometastatic uterine cervix cancer: a cooperative study of the korean radiation oncology group (KROG 14-11)","volume":"35","author":"Park","year":"2015","journal-title":"Anticancer Res"},{"key":"10.1016\/j.canrad.2023.06.012_bib0385","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/j.ygyno.2017.10.017","article-title":"Gynecologic Oncology Outcomes and patterns of relapse after de fi nitive radiation therapy for oligometastatic cervical cancer","volume":"148","author":"Ning","year":"2018","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.canrad.2023.06.012_bib0390","doi-asserted-by":"crossref","first-page":"e452","DOI":"10.1016\/S1470-2045(19)30171-8","article-title":"Optimising efficacy and reducing toxicity of anticancer radioimmunotherapy","volume":"20","author":"Deutsch","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.canrad.2023.06.012_bib0395","doi-asserted-by":"crossref","first-page":"4723","DOI":"10.1158\/1078-0432.CCR-19-4155","article-title":"Methodological development of combination drug and radiotherapy in basic and clinical research","volume":"26","author":"Chargari","year":"2020","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.canrad.2023.06.012_bib0400","first-page":"1","article-title":"Survival and control prognosticators of recurrent gynecological malignancies of the pelvis and para-aortic region treated with stereotactic body radiation","volume":"6","author":"Hasan","year":"2016","journal-title":"Therapy"},{"key":"10.1016\/j.canrad.2023.06.012_bib0405","series-title":"Stereotactic body radiation therapy for oligometastatic pulmonary tumors from cervical cancer","first-page":"175","author":"Hou","year":"2019"},{"key":"10.1016\/j.canrad.2023.06.012_bib0410","first-page":"396","article-title":"Clinical outcomes of stereotactic body radiotherapy in oligometastatic gynecological","volume":"27","author":"Laliscia","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/j.canrad.2023.06.012_bib0415","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/IGC.0000000000000869","article-title":"Clinical outcomes for stereotactic ablative radiotherapy in oligometastatic and oligoprogressive gynecological malignancies","volume":"27","author":"Mesko","year":"2017","journal-title":"Int J Gynecol Cancer Off J Int Gynecol Cancer Soc"},{"key":"10.1016\/j.canrad.2023.06.012_bib0420","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1136\/ijgc-2020-002230","article-title":"ESGO\/ESTRO\/ESP guidelines for the management of patients with endometrial carcinoma","volume":"31","author":"Concin","year":"2021","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.canrad.2023.06.012_bib0425","doi-asserted-by":"crossref","DOI":"10.1007\/s10147-022-02284-9","article-title":"JGOG2046: a feasibility study of neoadjuvant chemotherapy followed by debulking surgery for clinically diagnosed FIGO stage IVb endometrial cancer","author":"Nakanishi","year":"2023","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/j.canrad.2023.06.012_bib0430","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.radonc.2022.07.023","article-title":"Palliative radiotherapy in cancers of female genital tract: Outcomes and prognostic factors","volume":"175","author":"Kombathulma","year":"2022","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2023.06.012_bib0435","first-page":"239244","article-title":"Palliative pelvis radiotherapy for gynaecologic cancer","author":"Skliarenko","year":"2012","journal-title":"J Radiat Oncol"},{"key":"10.1016\/j.canrad.2023.06.012_bib0440","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1056\/NEJMoa2108330","article-title":"Lenvatinib plus pembrolizumab for advanced endometrial cancer","volume":"386","author":"Makker","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2023.06.012_bib0445","first-page":"529","article-title":"Stage IVB endometrial cancer: clinical course and survival of patients with single and multiples metastases","volume":"36","author":"Kraemer","year":"2015","journal-title":"Eur J Gynaecol Oncol"},{"key":"10.1016\/j.canrad.2023.06.012_bib0450","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1016\/j.ijrobp.2022.06.095","article-title":"Local treatment of the primary tumor patients with metastatic cancer (PRIME-TX): a meta-analysis","volume":"114","author":"Ryckman","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2023.06.012_bib0455","first-page":"40","article-title":"Short-course palliative radiation therapy leads to excellent bleeding control: a single centre retrospective study","volume":"14","author":"Sapienza","year":"2018","journal-title":"Clin Transl Radiat Oncol"},{"key":"10.1016\/j.canrad.2023.06.012_bib0460","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s13566-012-0050-y","article-title":"Palliative pelvis radiotherapy for gynaecologic cancer","volume":"1","author":"Skliarenko","year":"2012","journal-title":"J Radiat Oncol"},{"key":"10.1016\/j.canrad.2023.06.012_bib0465","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1006\/gyno.2001.6233","article-title":"10-Gy single-fraction pelvis irradiation for palliation and life prolongation in patients with cancer of cervix and corpus uteri","volume":"82","author":"Onsrud","year":"2001","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.canrad.2023.06.012_bib0470","doi-asserted-by":"crossref","first-page":"6099","DOI":"10.21873\/anticanres.16122","article-title":"Safety and efficacy of palliative radiotherapy (25Gy x 5 fractions) for Symptomatic pelvic tumors","volume":"42","author":"Aoshika","year":"2022","journal-title":"Anticancer Res"},{"key":"10.1016\/j.canrad.2023.06.012_bib0475","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.clon.2011.01.001","article-title":"A hypofractionated radiotherapy regimen (0-7-21) for advanced gynaecological cancer patients","volume":"23","author":"Yan","year":"2011","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/j.canrad.2023.06.012_bib0480","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.21873\/anticanres.13585","article-title":"Palliative short-course radiotherapy in advanced pelvic cancer: a phase II study (SHARON Project)","volume":"39","author":"Farina","year":"2019","journal-title":"Anticancer Res"},{"key":"10.1016\/j.canrad.2023.06.012_bib0485","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/0360-3016(93)90059-5","article-title":"Effect of rest interval on tumor and normal tissue response-A report of phase III study of accelerated split course palliative radiation for advanced pelvis malignancies (RTOG-8502)","volume":"25","author":"Spanos","year":"1993","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2023.06.012_bib0490","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1056\/NEJMoa1813181","article-title":"Adjuvant chemotherapy plus radiation for locally advanced endometrial cancer","volume":"380","author":"Matei","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/j.canrad.2023.06.012_bib0495","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/j.adro.2020.08.012","article-title":"Outcomes after salvage radiation therapy for recurrent endometrial cancer in patients with no prior adjuvant therapy: an institutional review","volume":"5","author":"Arden","year":"2020","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/j.canrad.2023.06.012_bib0500","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.3390\/cancers13061367","article-title":"Salvage radiation for pelvic relapse after surgically treated endometrial cancer","volume":"13","author":"Lindemann","year":"2021","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canrad.2023.06.012_bib0505","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.ygyno.2019.04.676","article-title":"Recurrent early stage endometrial cancer: patterns of recurrence and results of salvage therapy","volume":"154","author":"Francis","year":"2019","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.canrad.2023.06.012_bib0510","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.gore.2019.05.002","article-title":"Salvage treatment in recurrent endometrial cancer of the pelvis and peritoneal cavity","volume":"29","author":"McAlarnen","year":"2019","journal-title":"Gynecol Oncol Rep"},{"key":"10.1016\/j.canrad.2023.06.012_bib0515","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1136\/ijgc-2019-000822","article-title":"Clinical outcome of recurrent endometrial cancer: analysis of post-relapse survival by pattern of recurrence and secondary treatment","volume":"30","author":"Legge","year":"2020","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.canrad.2023.06.012_bib0520","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1097\/COC.0000000000000212","article-title":"Survival outcomes improved in contemporary cohort of patients with pelvic or abdominal recurrence after treatment for stade I\/II endometrial carcinoma","volume":"40","author":"Xu","year":"2017","journal-title":"Am J Clin Oncol"},{"key":"10.1016\/j.canrad.2023.06.012_bib0525","doi-asserted-by":"crossref","first-page":"4176","DOI":"10.3390\/cancers14174176","article-title":"Recurrent endometrial cancer: which is the best treatment? Systematic review of the Literature","volume":"14","author":"Restaino","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/j.canrad.2023.06.012_bib0530","article-title":"GEC-ESTRO (ACROP)-ABS-CBG Consensus brachytherapy target definition guidelines for recurrent endometrial and cervical tumors in the vagina","author":"Kamrava","year":"2022","journal-title":"Int J Radiat Oncol Biol Phys."},{"key":"10.1016\/j.canrad.2023.06.012_bib0535","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.ygyno.2015.07.096","article-title":"Management of nodal recurrences of endometrial cancer with IMRT","volume":"139","author":"Ho","year":"2015","journal-title":"Gynecol Oncol"},{"key":"10.1016\/j.canrad.2023.06.012_bib0540","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/j.brachy.2015.05.007","article-title":"Computed tomography planned interstitial brachytherapy for recurrent gynecologic cancer","volume":"14","author":"Amsbaugh","year":"2015","journal-title":"Brachytherapy"},{"key":"10.1016\/j.canrad.2023.06.012_bib0545","doi-asserted-by":"crossref","first-page":"173","DOI":"10.5114\/jcb.2016.61062","article-title":"Institutional experience using brachytherapy for the treatment of primary and recurrent pelvic malignancies","volume":"8","author":"Aridgides","year":"2016","journal-title":"J Contemp Brachytherapy"},{"key":"10.1016\/j.canrad.2023.06.012_bib0550","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1097\/CCO.0000000000000392","article-title":"Re-irradiation of cervical and endometrial cancer","volume":"29","author":"Llewelyn","year":"2017","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/j.canrad.2023.06.012_bib0555","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.brachy.2017.07.007","article-title":"MR- versus CT-based high-dose-rate interstitial brachytherapy for vaginal recurrence of endometrial cancer","volume":"16","author":"Kamran","year":"2017","journal-title":"Brachytherapy"},{"key":"10.1016\/j.canrad.2023.06.012_bib0560","doi-asserted-by":"crossref","first-page":"2830","DOI":"10.1200\/JCO.20.00818","article-title":"Stereotactic ablative radiotherapy for the comprehensive treatment of oligometastatic cancers: long-term results of the SABR-COMET phase II randomized trial","volume":"38","author":"Palma","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.canrad.2023.06.012_bib0565","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.jtcvs.2003.10.011","article-title":"Pulmonary metastases from uterine malignancies: results of surgical resection in 133 patients","volume":"127","author":"Anraku","year":"2004","journal-title":"J Thorac Cardiovasc Surg"},{"key":"10.1016\/j.canrad.2023.06.012_bib0570","doi-asserted-by":"crossref","first-page":"181","DOI":"10.3389\/fonc.2012.00181","article-title":"Phase II clinical trial of robotic stereotactic body radiosurgery for metastatic gynecologic malignancies","volume":"2","author":"Kunos","year":"2012","journal-title":"Front Oncol"},{"key":"10.1016\/j.canrad.2023.06.012_bib0575","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1055\/s-0041-1731576","article-title":"CyberKnife stereotactic ablative radiotherapy for recurrent or oligometastatic gynecological cancers","volume":"10","author":"Kataria","year":"2021","journal-title":"South Asian J Cancer"},{"key":"10.1016\/j.canrad.2023.06.012_bib0580","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1097\/IGC.0000000000000869","article-title":"Radiotherapy in oligometastatic and oligoprogressive gynecological malignancies","volume":"27","author":"Mesko","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.canrad.2023.06.012_bib0585","unstructured":"Choi CW, Cho CK, Yoo SY, Kim MS, Yang KM, Yoo HJ, et al. Image-guided stereotactic body radiation therapy in patients with isolated para-aortic lymoh node metastases from uterine cervical cancer."},{"key":"10.1016\/j.canrad.2023.06.012_bib0590","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1097\/IGC.0000000000000885","article-title":"Clinical outcomes of stereotactic body radiotherapy in oligometastatic gynecological cancer","volume":"27","author":"Laliscia","year":"2017","journal-title":"Int J Gynecol Cancer"},{"key":"10.1016\/j.canrad.2023.06.012_bib0595","doi-asserted-by":"crossref","first-page":"978140","DOI":"10.3389\/fonc.2022.978140","article-title":"Survival normogram for endometrial cancer with lung metastasis: a SEER database analysis","volume":"12","author":"Yan","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/j.canrad.2023.06.012_bib0600","doi-asserted-by":"crossref","first-page":"855314","DOI":"10.3389\/fsurg.2022.855314","article-title":"A new nomogram for predicting lung metastasis in newly diagnosed endometrial carcinoma patients: a study based on SEER","volume":"9","author":"Yuan","year":"2022","journal-title":"Front Surg"},{"key":"10.1016\/j.canrad.2023.06.012_bib0605","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/ijgo.13084","article-title":"Prognostic value of distant metastatic sites in stage IV endometrial cancer: a SEER database study of 2948 women","volume":"149","author":"Liu","year":"2000","journal-title":"Int J Gynaecol Obstet"},{"key":"10.1016\/j.canrad.2023.06.012_bib0610","doi-asserted-by":"crossref","first-page":"supplE621","DOI":"10.1016\/j.ijrobp.2021.07.1653","article-title":"Curative radiotherapy for stage IVB or recurrent uterine cancer presenting with supraclavicular or mediastinal lymph node metastasis","volume":"111","author":"Saito","year":"2021","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.canrad.2023.06.012_bib0615","first-page":"524","article-title":"Pelvis radiotherapy does not deteriorate the quality of life of women with gynecologic cancers in long-term follow-up: a 2 years prospective single-center study","volume":"13","author":"Yavas","year":"2017","journal-title":"J Cancer Res Ther"},{"key":"10.1016\/j.canrad.2023.06.012_bib0620","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ijsu.2015.01.001","article-title":"Survival impact of cytoreduction to microscopic disease for advanced stage cancer of the uterine corpus: a retrospective cohort study","volume":"14","author":"Alagkiozidis","year":"2015","journal-title":"Int J Surg"},{"key":"10.1016\/j.canrad.2023.06.012_bib0625","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.canrad.2021.11.009","article-title":"Radiotherapy of cervical cancer","volume":"26","author":"Chargari","year":"2022","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2023.06.012_bib0630","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/j.canrad.2022.06.016","article-title":"A complex situation","volume":"26","author":"Chargari","year":"2022","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.canrad.2023.06.012_bib0635","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.radonc.2019.11.005","article-title":"Recommendations from gynaecological (GYN) GEC-ESTRO working group - ACROP: Target concept for image guided adaptive brachytherapy in primary vaginal cancer","volume":"145","author":"Schmid","year":"2020","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.canrad.2023.06.012_bib0640","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.canrad.2021.11.016","article-title":"Radiotherapy for endometrial cancer","volume":"26","author":"Chargari","year":"2022","journal-title":"Cancer Radiother"}],"container-title":["Cancer\/Radioth\u00e9rapie"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321823001257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1278321823001257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T12:37:35Z","timestamp":1761136655000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1278321823001257"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":64,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S1278321823001257"],"URL":"https:\/\/doi.org\/10.1016\/j.canrad.2023.06.012","relation":{},"ISSN":["1278-3218"],"issn-type":[{"value":"1278-3218","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Place of radiotherapy for treatment of metastatic cervical, vaginal and endometrial uterine cancer","name":"articletitle","label":"Article Title"},{"value":"Cancer\/Radioth\u00e9rapie","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canrad.2023.06.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Soci\u00e9t\u00e9 fran\u00e7aise de radioth\u00e9rapie oncologique (SFRO). Published by Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}